Codex DNA Shares Move Higher On Licensing, Supply Deal With TriLink For mRNA Capping Tech


Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


  • Codex DNA Inc (NASDAQ:DNAYhas announced a licensing and supply agreement with TriLink Biotechnologies, part of Maravai LifeSciences Holdings Inc (NASDAQ:MRVI) for CleanCap technology. 
  • Codex DNA will integrate the mRNA capping technology into its suite of automated mRNA synthesis kits for the BioXp system and within the company's BioFoundry Services offering.
  • Together, the technologies are expected to increase productivity and yields for mRNA synthesis workflows.
  • Customers will now have the option to generate up to 16 biologically active mRNA constructs at a yield of at least 10 micrograms each from fully de novo synthesized and error-corrected genes in a single automated run. 
  • Price Action: DNAY shares are up 10.4% at $17.50, while MRVI shares are down 2.37% at $39.38 during the market session on the last check Wednesday.

Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: NewsHealth CareContractsSmall CapMoversTrading IdeasGeneralBriefs